Publication | Closed Access

Pharmacokinetic Features and Presence of Antidrug Antibodies Associate With Response to Infliximab Induction Therapy in Patients With Moderate to Severe Ulcerative Colitis

InflammationAnti-inflammatoryAutoimmune DiseaseAllergyAntidrug Antibodies AssociateImmunologyGastroenterologyAutoimmunitySevere Ulcerative ColitisUlcerative ColitisMedicineRheumatoid ArthritisInfliximab Induction Therapy